The GENE.01 humanoid robot is equipped with a full-body tactile skin, a distributed network of touch and force sensors ...

Generative Bionics, an Italian company developing Physical AI powered humanoid robots, unveiled its first concept at CES 2026 ...

Beta Bionics Inc. was born out of a father’s desire to improve his son’s quality of life following a diabetes diagnosis. Today, 10 years after its founding, it’s now a publicly traded company. The ...

Net sales of $17.6 million, up 36% compared to $12.9 million in the first quarter of 2024. Durable Medical Equipment (DME) channel net sales of $13.8 million, up 14% compared to $12.1 million in the ...

Beta Bionics, Inc., a leader in diabetes management solutions, announced it will release its first quarter financial results for 2025 on May 6, 2025, after market close. Management will hold a ...

SAN RAFAEL, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today ...

Earnings call Ekso Bionics reported Q1 2025 revenue of $3.4M, down 11% YoY due to softness in enterprise health sales, but gross margin improved to 54% from 52%. Net loss narrowed to $2.9M from $3.4M.

One day before long, we’ll be at the point where technology will be “as good as a cure” for many of us — because a truly closed-loop automated diabetes management system is getting so close we can ...

BofA analyst Travis Steed raised the firm’s price target on Beta Bionics (BBNX) to $33 from $30 and keeps a Buy rating on the shares as the firm ...